Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form SD
SPECIALIZED DISCLOSURE REPORT
Perseon Corporation
(Exact Name of Registrant as Specified in Charter)
|
|
|
Delaware
|
001-32526
|
75-1590407
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File No.)
|
(I.R.S. Employer Identification Number)
|
|
|
|
2188 West 2200 South, Salt Lake City, Utah |
|
84119 |
(Address of Principal Executive Offices)
|
|
(Zip Code) |
|
|
|
Scott Mayfield |
|
801-972-5555 |
(Name and telephone number, including area code, of the person to contact in connection with this report.)
|
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:
Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2014. ý
Section 1 Conflict Minerals Disclosure
Item 1.01 Conflict Minerals Disclosure and Report, Exhibit
Conflict Minerals Disclosure
A copy of Perseon (formerly BSD Medical) Corporation’s Conflict Minerals Report is filed as Exhibit 1.01 hereto and is publicly available at www.perseonmedical.com.
Item 1.02 Exhibit
Perseon has filed, as an exhibit to this Form SD, the Conflict Minerals Report required by Item 1.01.
Section 2 Exhibit
Item 2.01 Exhibits
The following exhibit is filed as part of this report:
Exhibit 1.01 — Conflict Minerals Report as required by Item 1.01 and 1.02 of this Form.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
Perseon Corporation
Date: May 29, 2015
By: /s/ William S. Barth
Name: William S. Barth
Title: Chief Financial Officer